Delcath Systems Inc. (NASDAQ: DCTH) Stock Information | RedChip

Delcath Systems Inc. (NASDAQ: DCTH)


$10.8500
-0.1600 ( -2.08% ) 111.7K

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Market Data


Open


$10.8500

Previous close


$11.0100

Volume


111.7K

Market cap


$352.03M

Day range


$10.7300 - $11.1250

52 week range


$3.7000 - $13.3011

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 93 Nov 08, 2024
8-k 8K-related 14 Nov 08, 2024
4 Insider transactions 1 Nov 01, 2024
4 Insider transactions 1 Nov 01, 2024
4 Insider transactions 1 Nov 01, 2024
4 Insider transactions 1 Oct 23, 2024
8-k 8K-related 14 Oct 17, 2024
8-k 8K-related 14 Aug 29, 2024
8-k 8K-related 17 Aug 28, 2024
10-q Quarterly Reports 92 Aug 05, 2024

Latest News